Write-up and recap coming soon!
Time: Thursday, Sept 26, 2024 at 9am PST / 12 EST / 6pm Paris.
As we age, the risk of developing cancer increases. But how can we better understand, screen for, and mitigate this growing threat?
Cancer is one of the leading causes of death worldwide, responsible for nearly 1 in 5 deaths annually in the U.S (>600,000 people each year).
Cancer is a complex group of diseases marked by abnormal cell growth that can invade or spread to other parts of the body. Despite significant research and advancements, fully understanding, screening, and treating cancer remains a challenge. However, new tools and techniques are emerging to offer more personalized and proactive approaches.
In this month’s Longevity Connect webinar, you’ll discover how cutting-edge genetic and epigenetic methods—along with innovations like liquid biopsies and DNA testing—can help you assess and reduce your cancer risk.
Learn how these advancements are transforming cancer prevention and longevity strategies, empowering you to take control of your health as you age.
Key Topics:
- 💥 Cancer as a Complex and Heterogeneous Disease: What is cancer? What are the fundamental mechanisms that drive it, from genetic mutations (in oncogenes and tumor suppressor genes) to environmental factors (like smoking and radiation), and how do these factors impact your health as you age?
- 🩺 Cancer Screening Guidelines: When should you be screened for cancer? What tests to consider, like colonoscopy, mammograms, PSA testing for prostate cancer? And how do these guidelines change as we age?
- 💉 Can Liquid Biopsies Detect Cancer Risk?: Considering Cancer Tests from Galleri, Guardant or others for early cancer detection? How do these advanced non-invasive tests work, and what can they reveal about your cancer risk and progression?
- 🧬 What Can Genetic and Epigenetic Tests Tell You?: How do your genetic predispositions (like BRCA gene) and epigenetic markers (like biological age and GrimAge) offer early insights into your cancer risk and disease prediction?
- 📊 Monitoring Cancer Risk for Longevity Trials & Treatment Programs: What role does cancer risk monitoring play in personalizing longevity trials and treatment plans?
- 🕰️ Epigenetic Age & Cancer Risk?: How can DNA methylation clocks help assess and predict cancer risk and track its progression over time?
- 🛡️ How Can You Lower Your Cancer Risk?: What are some evidence-based strategies, from lifestyle changes to emerging therapies, that can reduce cancer risk and promote longevity? Ex. regular exercise, metformin, rapamycin, and diets for reducing cancer risk.
- 🚀 What Are the Latest Advances in Cancer Treatment?: Explore cutting-edge cancer therapies that are transforming treatment today, from immunotherapy to targeted gene therapy.
Don’t miss this opportunity to advance your knowledge and strategies for leveling up your longevity intervention strategies.
Hosted by Clock Foundation’s Executive Director Bobby Brooke and Head of Product Mark Koester.
